Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of KLHL2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Estradiol results in decreased expression of KLHL2 mRNA | CTD | PMID:19484750 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of KLHL2 mRNA | CTD | PMID:32741896 | 17beta-estradiol | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of KLHL2 mRNA | CTD | PMID:22217510 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KLHL2 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KLHL2 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KLHL2 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of KLHL2 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | KLHL2 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of KLHL2 gene | CTD | PMID:31601247 | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of KLHL2 mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of KLHL2 mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases methylation | ISO | KLHL2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of KLHL2 gene | CTD | PMID:27153756 | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLHL2 mRNA] | CTD | PMID:17460151 | antirheumatic drug | decreases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of KLHL2 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of KLHL2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases methylation | ISO | KLHL2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of KLHL2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | Klhl2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of KLHL2 3' UTR more ... | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of KLHL2 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of KLHL2 mRNA | CTD | PMID:21569818 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of KLHL2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of KLHL2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KLHL2 mRNA | CTD | PMID:30816183 and PMID:34947998 | buta-1,3-diene | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of KLHL2 mRNA | CTD | PMID:29038090 | calcium silicate | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | calcium silicate results in decreased expression of KLHL2 mRNA | CTD | PMID:29279043 | carbon nanotube | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | clorgyline | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of KLHL2 mRNA | CTD | PMID:19691856 | cobalt dichloride | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of KLHL2 mRNA | CTD | PMID:19376846 | crocidolite asbestos | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of KLHL2 mRNA | CTD | PMID:29279043 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of KLHL2 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of KLHL2 mRNA | CTD | PMID:27989131 | dorsomorphin | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of KLHL2 mRNA | CTD | PMID:25896364 | doxorubicin | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of KLHL2 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of KLHL2 mRNA | CTD | PMID:35436446 | Erionite | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | erionite results in decreased expression of KLHL2 mRNA | CTD | PMID:29279043 | ethanol | affects splicing | ISO | Klhl2 (Mus musculus) | 6480464 | Ethanol affects the splicing of KLHL2 mRNA | CTD | PMID:30319688 | ethanol | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of KLHL2 mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of KLHL2 mRNA | CTD | PMID:24136188 | fulvestrant | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of KLHL2 gene | CTD | PMID:31601247 | isoprenaline | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of KLHL2 mRNA | CTD | PMID:20003209 | maneb | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of KLHL2 mRNA | CTD | PMID:36117858 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of KLHL2 mRNA | CTD | PMID:30467583 | methylseleninic acid | affects expression | ISO | KLHL2 (Homo sapiens) | 6480464 | methylselenic acid affects the expression of KLHL2 mRNA | CTD | PMID:14617803 | nickel atom | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Nickel results in increased expression of KLHL2 mRNA | CTD | PMID:12540486 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLHL2 mRNA] | CTD | PMID:17460151 | ozone | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of KLHL2 mRNA | CTD | PMID:35430440 | paraquat | multiple interactions | ISO | Klhl2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of KLHL2 mRNA | CTD | PMID:36117858 | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of KLHL2 mRNA | CTD | PMID:20345932 | pirinixic acid | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of KLHL2 mRNA | CTD | PMID:17426115 | propiconazole | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of KLHL2 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of KLHL2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA | CTD | PMID:27188386 | sulforaphane | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | sulforaphane results in decreased expression of KLHL2 mRNA | CTD | PMID:30529165 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of KLHL2 mRNA | CTD | PMID:32741896 | tetrachloromethane | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of KLHL2 mRNA | CTD | PMID:31919559 | titanium dioxide | increases expression | ISO | Klhl2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of KLHL2 mRNA | CTD | PMID:27760801 | titanium dioxide | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of KLHL2 mRNA | CTD | PMID:29264374 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL2 mRNA | CTD | PMID:25729387 | tremolite asbestos | decreases expression | ISO | Klhl2 (Mus musculus) | 6480464 | tremolite results in decreased expression of KLHL2 mRNA | CTD | PMID:29279043 | trichostatin A | decreases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of KLHL2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | KLHL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Urethane results in increased expression of KLHL2 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | KLHL2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of KLHL2 mRNA | CTD | PMID:23179753 more ... | |